Catalyst Wire Dossier Catalyst Wire Dossier

nivolumab plus cisplatin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nivolumab plus cisplatin, covering 2021-08-09 to 2021-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer [Phase 3]

See pricing